[
    {
        "question": "Which of the following anticancer drug can cause flagellated dermatitis?",
        "exp": "FLAGELLATED DERMATITIS: It is characterised by pruritic, erythematous, linear streaks that resemble whiplash marks, hence the name flagellated. Bleomycin is metabolized by an enzyme hydrolase. This enzyme is deficient in skin and lungs. Therefore, the major adverse effects of bleomycin is related to skin (flagellated dermatitis) and lungs (pulmonary fibrosis) OTHER CAUSES OF FLAGELLATED DERMATITIS: DRUGS: BLEOMYCIN, DOCETAXEL, BENDAMUSTINE RHEUMATOLOGICAL CAUSES: DERMATOMYOSITIS, ADULT ONSET STILL'S DISEASE TOXINS: SHIITAKE MUSHROOMS",
        "cop": 4,
        "opa": "Cisplatin",
        "opb": "L-asparginase",
        "opc": "Doxorubicin",
        "opd": "Bleomycin",
        "subject_name": "Pharmacology",
        "topic_name": "Cytotoxic Anticancer Drugs",
        "id": "11aa7d32-e159-4432-823e-85d8ee9f8c2a",
        "choice_type": "single"
    },
    {
        "question": "Hand and foot syndrome is an adverse effect of:",
        "exp": "Capecitabine and 5-FU can cause hand and foot syndrome. Diarrhea is the most common adverse effect of 5-FU. 5-FU can also cause bone marrow suppression. Drugs commonly implicated are: Capecitabine 5-Fluorouracil Cytarabine Pemetrexed Doxorubicin",
        "cop": 1,
        "opa": "5-Fluorouracil",
        "opb": "Bleomycin",
        "opc": "Etoposide",
        "opd": "Actinomycin D",
        "subject_name": "Pharmacology",
        "topic_name": "Cytotoxic Anticancer Drugs",
        "id": "3c64e4ad-8d9c-4fbc-9065-c5d1bed748ed",
        "choice_type": "single"
    },
    {
        "question": "A patient was given radiotherapy for head and neck cancer. After 6 months chemotherapy was staed. The patient presented with the features shown in Figure after sta of chemotherapy. It is likely due to which drug?",
        "exp": "The history and the figure shows the characteristic 'Radiation recall syndrome'. It is caused by Doxorubicin (Anthracyclines).",
        "cop": 1,
        "opa": "Doxorubicin",
        "opb": "Cisplatin",
        "opc": "Imatinib",
        "opd": "Methotrexate",
        "subject_name": "Pharmacology",
        "topic_name": "Cytotoxic Anticancer Drugs",
        "id": "94945444-c185-48b1-b524-663e537484a9",
        "choice_type": "single"
    },
    {
        "question": "The mechanism of anticancer action of fluorouracil is:",
        "exp": "5-Fluorouracil (5-FU) is an antimetabolite. It is a thymidine analogue and acts by conversion to 5'-d. UMP. Latter inhibits the formation of d. TMP and results in thymineless death of cells. Option 1 is mechanism of alkylating agents like cyclophosphamide Option 3: methotrexate is example of DHFRase inhibitor Option 4: Vincristine like drugs act by inhibiting mitotic spindle",
        "cop": 2,
        "opa": "Cross linking of double stranded DNA and the resulting inhibition of DNA replication and transcription",
        "opb": "Cytotoxicity resulting from a metabolite that interferes with the production of d. TMP",
        "opc": "Irreversible inhibition of dihydrofolic acid reductase",
        "opd": "Inhibiting the formation of mitotic spindle",
        "subject_name": "Pharmacology",
        "topic_name": "Cytotoxic Anticancer Drugs",
        "id": "c4ed2a75-9a75-44e0-b7e7-20f7bf283a53",
        "choice_type": "single"
    },
    {
        "question": "Which of the following is a dihydrofolate reductase inhibitor?",
        "exp": "Methotrexate, pemetrexed and pralatrexate are the inhibitors of dihydrofolate reductase (DHFRase). These drugs also inhibit Thymidylate Synthase (TS) and the enzymes involved in early purine synthesis. Methotrexate is the drug of choice for the treatment of choriocarcinoma. Methotrexate is also indicated in the management of rheumatoid ahritis, psoriasis and ectopic pregnancy. Adverse effects of methotrexate are bone marrow suppression and mucositis.",
        "cop": 2,
        "opa": "Alcohol",
        "opb": "Methotrexate",
        "opc": "Cimetidine",
        "opd": "Erythromycin",
        "subject_name": "Pharmacology",
        "topic_name": "Cytotoxic Anticancer Drugs",
        "id": "be5c87a5-6d8f-4e84-ba47-c87ae6ce5326",
        "choice_type": "single"
    },
    {
        "question": "Sterility is caused by:",
        "exp": "Sterility and secondary leukemias are distinctive adverse effects of alkylating agents. Other adverse effects of alkylating agents: BM depression Alopecia Mucositis - Diarrhoea Hyperuricemia",
        "cop": 2,
        "opa": "Vinca alkaloids",
        "opb": "Alkylating agents",
        "opc": "Antimetabolites",
        "opd": "Actinomycin D",
        "subject_name": "Pharmacology",
        "topic_name": "Cytotoxic Anticancer Drugs",
        "id": "efcb2874-d82b-4f37-981d-c6103bb58273",
        "choice_type": "single"
    },
    {
        "question": "Which of the following is a new drug approved for the treatment of Breast Cancer?",
        "exp": "Palbociclib: MOA: It acts by inhibiting CDK-4, CDK-6. ROUTE: Oral drug USES: It is approved for Advanced or Metastatic Breast Cancer (ER+ve and HER2-ve) S/E: Neutropenia, Leukopenia, infections, stomatitis, fatigue, nausea, anemia, headache, diarrhea and Thrombocytopenia. Palbociclib is a substrate and an inhibitor of CYP3. A4. Patients should avoid concomitant use of strong CYP3A inhibitors (Indinavir, Itraconazole, Ketoconazole, Lopinavir/Ritonavir etc). Patients should avoid breastfeeding while taking palbociclib. Ruxolitinib It is Janus Kinase inhibitor used for Myelofibrosis Trametinib It is MEK inhibitor used for Malignant Melanoma in combination with Dabrafenib (BRAF inhibitor) Cobimetinib It is MEK inhibitor used for Malignant Melanoma in combination with Vemurafenib (BRAF inhibitor)",
        "cop": 3,
        "opa": "Trametinib",
        "opb": "Ruxolitinib",
        "opc": "Palbociclib",
        "opd": "Cobimetinib",
        "subject_name": "Pharmacology",
        "topic_name": "Cytotoxic Anticancer Drugs",
        "id": "2372e503-0953-4da7-9d8b-bf50a6dec6bf",
        "choice_type": "single"
    },
    {
        "question": "Bleomycin toxicity affects which organ predominantly?",
        "exp": "Bleomycin is metabolized by bleomycin hydrolase. This enzyme is deficient in skin and lungs. Therefore, the major adverse effects of bleomycin are: Flagellated pigmentation of skin Pulmonary fibrosis",
        "cop": 2,
        "opa": "Bone marrow",
        "opb": "Lungs",
        "opc": "Liver",
        "opd": "RBC",
        "subject_name": "Pharmacology",
        "topic_name": "Cytotoxic Anticancer Drugs",
        "id": "65904ecc-244d-40f4-84ae-070b7086172c",
        "choice_type": "single"
    },
    {
        "question": "Which of the following antineoplastic drugs should not be administered to a chronic alcoholic patient due to risk of development of disulfiram like reaction?",
        "exp": "Disulfiram like reaction can be caused by Cyclic: Chlorpropamide Cefoperazone G: Griseofulvin M: Metronidazole P: Procarbazine",
        "cop": 2,
        "opa": "Dacarbazine",
        "opb": "Procarbazine",
        "opc": "Melphalan",
        "opd": "Hydroxyurea",
        "subject_name": "Pharmacology",
        "topic_name": "Cytotoxic Anticancer Drugs",
        "id": "7476a7e2-941f-418d-aa12-c4beaf14ddd0",
        "choice_type": "single"
    },
    {
        "question": "Pentostatin acts by inhibiting:",
        "exp": "* Pentostatin and cilastatin are not statins i. e. these do not act by inhibiting HMG-CoA reductase. * Pentostatin acts by inhibiting adenosine deaminase. * It is used for the treatment of hairy cell leukemia. * Drug of choice for hairy cell leukemia is cladribine.",
        "cop": 3,
        "opa": "RNA dependent DNA polymerase",
        "opb": "Aldolase",
        "opc": "Adenosine deaminase",
        "opd": "Adenylyl cyclase",
        "subject_name": "Pharmacology",
        "topic_name": "Cytotoxic Anticancer Drugs",
        "id": "f7338862-e337-4204-b30e-79490415e023",
        "choice_type": "single"
    },
    {
        "question": "Which of the following drug can cause Delayed Bone Marrow Suppression leading to Sustained Neutropenia?",
        "exp": "NITROSOUREAS: MOA: Alkylating agent DRUGS: CARMUSTINE, LOMUSTINE, SEMUSTINE. USES: Can cross BBB thereby used in Brain tumors. S/E: Delayed Bone Marrow Suppression resulting in Sustained Neutropenia.",
        "cop": 4,
        "opa": "Vincristine",
        "opb": "Carboplatin",
        "opc": "Melphalan",
        "opd": "Carmustine",
        "subject_name": "Pharmacology",
        "topic_name": "Cytotoxic Anticancer Drugs",
        "id": "585856d7-6cb4-44c1-8bc2-2cfad1bdb54e",
        "choice_type": "single"
    },
    {
        "question": "Topical mitomycin-C is used in",
        "exp": "Mitomycin is an anti-tumor antibiotic with alkylating agent like propey. It is used in superficial cancer of urinary bladder. The drug has radiomimetic effects, and also sensitizes hypoxic tumor cells to the effects of hypoxia. Application of topical mitomycin C after endoscopic dilation of laryngotracheal stenosis reduces the rate of restenosis.",
        "cop": 2,
        "opa": "Sturge-Weber syndrome",
        "opb": "Laryngotracheal stenosis",
        "opc": "Endoscopic angiofibroma",
        "opd": "Skull base osteomyelitis",
        "subject_name": "Pharmacology",
        "topic_name": "Cytotoxic Anticancer Drugs",
        "id": "9090b63a-99d0-4b4b-9ab6-dc856e375ae4",
        "choice_type": "single"
    },
    {
        "question": "Roopmati, A 56-year-old female with lymph-node-positive breast cancer was treated with systemic chemotherapy. Four weeks later, she developed frequent urination, suprapubic pain, dysuria, and hematuria. Which of the following could have prevented this patient's condition?",
        "exp": "The patient described in the question has hemorrhagic cystitis caused by drugs like cyclophosphamide and ifosfamide. Hemorrhagic cystitis during therapy with cyclophosphamide or ifosfamide is caused by the urinary excretion of the toxic metabolite acrolein. This can be prevented by aggressive hydration, bladder irrigation, and administration of mesna, compound that binds acrolein in the urine.",
        "cop": 2,
        "opa": "Folinic acid",
        "opb": "Mesna",
        "opc": "Dexrazoxane",
        "opd": "Amifostine",
        "subject_name": "Pharmacology",
        "topic_name": "Cytotoxic Anticancer Drugs",
        "id": "dd5bea2f-bbe9-4d47-9c03-6ebcc5ac843c",
        "choice_type": "single"
    },
    {
        "question": "Which of the following drugs is used as an immunosuppressant but lacks anticancer activity?",
        "exp": "Azathioprine is an antimetabolite that is used as an immunosuppressant but not as an anti-neoplastic drug. It is a prodrug and is conveed to its active metabolite (6-mercaptopurine) in the lymphoid cells only.",
        "cop": 3,
        "opa": "Methotrexate",
        "opb": "6-Mercaptopurine",
        "opc": "Azathioprine",
        "opd": "5-Fluorouracil",
        "subject_name": "Pharmacology",
        "topic_name": "Cytotoxic Anticancer Drugs",
        "id": "5116fbd3-832b-493c-8841-b66a356c1879",
        "choice_type": "single"
    },
    {
        "question": "Which of the following anticancer drug causes nephrotoxicity as an adverse effect?",
        "exp": "Cisplatin can result in three impoant adverse effects: Nephrotoxicity Ototoxicity Vomiting",
        "cop": 4,
        "opa": "Imatinib",
        "opb": "Irinotecan",
        "opc": "Bleomycin",
        "opd": "Cisplatin",
        "subject_name": "Pharmacology",
        "topic_name": "Cytotoxic Anticancer Drugs",
        "id": "f003e65a-8873-4bc5-8fbf-aac46de83b48",
        "choice_type": "single"
    },
    {
        "question": "A 45 year old female was diagnosed with breast carcinoma. She was operated and is taking tamoxifen therapy for the last 1 year. Now she is complaining of bleeding per vaginum. If this is due to the adverse effect of tamoxifen, the most likely cause is:-",
        "exp": "- Tamoxifen and Toremifene are selective estrogen receptor modulators (SERMs) that are useful for chemoprevention as well as treatment of both early stage and metastatic breast carcinoma. - These increase the risk of endometrial carcinoma.",
        "cop": 2,
        "opa": "Development of bleeding disorder",
        "opb": "Development of endometrial carcinoma",
        "opc": "Development of ovarian carcinoma",
        "opd": "Development of cervical cancer",
        "subject_name": "Pharmacology",
        "topic_name": "Cytotoxic Anticancer Drugs",
        "id": "10e20c14-480e-4884-bc2d-86df11ecba4f",
        "choice_type": "single"
    },
    {
        "question": "A 56-year-old female with lymph-node-positive breast cancer was treated with systemic chemotherapy. Four weeks later, she developed frequent urination, suprapubic pain, dysuria, and hematuria. Which of the following could have prevented this patient's condition?",
        "exp": "The patient described in the question has hemorrhagic cystitis caused by drugs like cyclophosphamide and ifosfamide. Hemorrhagic cystitis during therapy with cyclophosphamide or ifosfamide is caused by the urinary excretion of the toxic metabolite acrolein. This can be prevented by aggressive hydration, bladder irrigation, and administration of mesna, a sulfhydryl compound that binds acrolein in the urine.",
        "cop": 2,
        "opa": "Folinic acid",
        "opb": "Mesna",
        "opc": "Dexrazoxane",
        "opd": "Amifostine",
        "subject_name": "Pharmacology",
        "topic_name": "Cytotoxic Anticancer Drugs",
        "id": "44e47a1f-80d8-4320-bb2e-003502b72e90",
        "choice_type": "single"
    },
    {
        "question": "Which anti-cancer drug affects DNA as well as RNA?",
        "exp": "Actinomycin-D is one of the anti-tumor antibiotic. It has two mechanisms of action: - It blocks RNA transcription by interfering with template function of DNA. - It causes single strand breaks in the DNA. It is used in the treatment of Wilm's tumor and rhabdomyosarcoma.",
        "cop": 3,
        "opa": "5-FU",
        "opb": "Methotrexate",
        "opc": "Actinomycin-D",
        "opd": "Etoposide",
        "subject_name": "Pharmacology",
        "topic_name": "Cytotoxic Anticancer Drugs",
        "id": "ee803e31-7413-4e72-97fb-a4d224bc7211",
        "choice_type": "single"
    },
    {
        "question": "Which of the following drugs is not used in prostate carcinoma?",
        "exp": "Prostatic carcinoma results due to excessive testosterone. Testosterone is conveed to dihydrotestosterone (DHT) by 5-a-reductase. DHT is responsible for prostatic growth. Flutamide is an androgen receptor antagonist whereas finasteride is 5-a-reductase inhibitor. Diethylstilbestrol is an estrogen. It will cause feedback inhibition of pituitary and hypothalamus. It was also used previously for prostatic carcinoma.",
        "cop": 3,
        "opa": "Finasteride",
        "opb": "Diethylstilbesterol",
        "opc": "Testosterone",
        "opd": "Flutamide",
        "subject_name": "Pharmacology",
        "topic_name": "Cytotoxic Anticancer Drugs",
        "id": "299f1660-dd46-4aa1-b7ae-33cc30fd87b1",
        "choice_type": "single"
    },
    {
        "question": "Most common agent among the following which is associated with agranulocytosis is:-",
        "exp": "Agranulocytosis results due to bone marrow suppression caused by alkylating agents. Alkylating agents are anti-cancer drugs causing the maximum bone marrow suppression. Other drugs causing agranulocytosis are: * Carbimazole * Sulfasalazine * Clozapine * Quinine",
        "cop": 2,
        "opa": "Steroids",
        "opb": "Alkylating agents",
        "opc": "Paracetamol",
        "opd": "Endotoxemia",
        "subject_name": "Pharmacology",
        "topic_name": "Cytotoxic Anticancer Drugs",
        "id": "5c754482-e685-4b55-9b71-72778b37bf6c",
        "choice_type": "single"
    },
    {
        "question": "Which of the following drug is not categorized under anti-VEGF agents?",
        "exp": "DRUGS INHIBITING VEGF PATHWAY Vascular Endothelial Growth Factor pathway is involved in causing angiogenesis. Drugs inhibiting this pathway are used as anti-angiogenic drugs. 5- Fluorouracil is not a anti VEGF agent.",
        "cop": 2,
        "opa": "Sunitinib",
        "opb": "5-Fluorouracil",
        "opc": "Ranibizumab",
        "opd": "Bevacizumab",
        "subject_name": "Pharmacology",
        "topic_name": "Cytotoxic Anticancer Drugs",
        "id": "0889de08-6f51-40bf-9627-00f415722687",
        "choice_type": "single"
    },
    {
        "question": "Hemorrhagic cystitis is caused by:-",
        "exp": "Cyclophosphamide and Ifosfamide can cause hemorrhagic cystitis. This is due to the compound acrolein Mesna is used to prevent this adverse effect. Specific Adverse Effect of Anticancer Drugs See the diagram very carefully: Cisplatin: Ear look like C(so Cisplatin cause ototoxicity), similarly Kidney look like C (So Cisplatin cause nephrotoxicity) and mouth look like C (Cisplatin is most emetogenic) Tamoxifen: Eyes look like T (So, tamoxifen affects eye causing cataract and retinopathy) Vincristine and Vinblastine: The cap look like V (means vinca drugs release ADH from brain) and limbs look like V (means vinca drugs act in periphery causing peripheral neuropathy) Lungs look like B, So Bleomycin and Busulfan cause pulmonary fibrosis Heart look like D, So Doxorubicin like drugs cause cardiotoxicity Liver look like figure of six, so 6-mercaptopurine and 6- Thioguanine are hepatotoxic Only complete cycle in the diagram is of bladder, so Cyclophosphamide cause hemorrhagic cystitis.",
        "cop": 3,
        "opa": "Methotrexate",
        "opb": "Melphalan",
        "opc": "Cyclophosphamide",
        "opd": "Busulfan",
        "subject_name": "Pharmacology",
        "topic_name": "Cytotoxic Anticancer Drugs",
        "id": "9cef0e94-77e7-4bdd-b5c2-4031f268cc0a",
        "choice_type": "single"
    },
    {
        "question": "Maintenance of high urinary pH is impoant during methotrexate treatment because:",
        "exp": "Methotrexate is a weak acid and is reabsorbed in acidic urinary pH. Higher plasma concentration may result in toxicity. Therefore, to decrease the reabsorption through renal tubules, high urinary pH must be maintained.",
        "cop": 4,
        "opa": "Bladder irritation is reduced",
        "opb": "It decreases renal tubular secretion of methotrexate",
        "opc": "Leucovorin toxicity is increased in a dehydrated patient",
        "opd": "Methotrexate is a weak acid",
        "subject_name": "Pharmacology",
        "topic_name": "Cytotoxic Anticancer Drugs",
        "id": "039fdcc1-3fd3-40d2-93e0-4bb9339a7ea2",
        "choice_type": "single"
    },
    {
        "question": "Vinca alkaloids act on which phase of cell cycle?",
        "exp": "S phase specific drugs:- Antimetabolite - antifolate, purine, pyrimidine analogues M phase specific drugs:- Vinca alkaloids Taxanes Anti microtubule inhibitors",
        "cop": 4,
        "opa": "G1 phase",
        "opb": "S phase",
        "opc": "G2 phase",
        "opd": "M phase",
        "subject_name": "Pharmacology",
        "topic_name": "Cytotoxic Anticancer Drugs",
        "id": "d031cd98-cae1-450a-b8c9-ac331838f946",
        "choice_type": "single"
    },
    {
        "question": "Which of the following drug can result in cerebellar toxicity?",
        "exp": "Cytarabine is pyrimidine analogue At higher dose it is known to cause cerebellar toxicity like ataxia, dysahria. other side effects- myelosuppression, mucositis, nausea and vomiting. Cyclophosphamide causes hemorrhagic cystitis Cisplatin is most emetogenic anticancer drug. Actinomycin D and doxorubicin can cause vomiting, stomatitis, diarrhoea, erythema, desquamation of skin, alopecia and bone marrow suppression.",
        "cop": 3,
        "opa": "Cyclophosphamide",
        "opb": "Cisplatin",
        "opc": "Cytarabine",
        "opd": "Actinomycin D",
        "subject_name": "Pharmacology",
        "topic_name": "Cytotoxic Anticancer Drugs",
        "id": "f922ea87-3354-45cb-9099-262391adc268",
        "choice_type": "single"
    },
    {
        "question": "Which of the following is a common side effect of cisplatin?",
        "exp": "Common side effect of cisplatin is vomiting. Drug of choice for cisplatin induced vomiting is 5. HT3 antagonist like ondansetron.",
        "cop": 2,
        "opa": "Diarrhea",
        "opb": "Vomiting",
        "opc": "Pulmonary fibrosis",
        "opd": "Alopecia",
        "subject_name": "Pharmacology",
        "topic_name": "Cytotoxic Anticancer Drugs",
        "id": "41f1e6bd-71a3-4fc6-a660-e748082b0cef",
        "choice_type": "single"
    },
    {
        "question": "Pulmonary fibrosis is an adverse effect of which of the following anti-cancer drugs?",
        "exp": "Anticancer drugs causing pulmonary fibrosis are Bleomycin Busulfan Methotrexate Cyclophosphamide Carmustine",
        "cop": 3,
        "opa": "Mitomycin C",
        "opb": "Hydroxyurea",
        "opc": "Bleomycin",
        "opd": "Cisplatin",
        "subject_name": "Pharmacology",
        "topic_name": "Cytotoxic Anticancer Drugs",
        "id": "3c9062a8-a44b-4730-8e23-b940bda8c849",
        "choice_type": "single"
    }
]